The University of Chicago Header Logo

Connection

Philip Charles Hoffman to Erythropoietin

Back to Details
This is a "connection" page, showing publications Philip Charles Hoffman has written about Erythropoietin.
Philip Charles Hoffman
Connection Strength
0.081
Erythropoietin
  1. Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). J Thorac Oncol. 2008 Oct; 3(10):1159-65.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.